JNK pathway signaling : a novel and smarter therapeutic targets for various biological diseases
JNK pathway regulates various physiological processes including inflammatory responses, cell differentiation, cell proliferation, cell death, cell survival and expression of proteins. Deregulation of JNK is linked with various diseases including neurodegenerative disease, autoimmune disease, diabetes, cancer, cardiac hypertrophy and asthma. Three distinct genes JNK1, JNK2 and JNK3 have been identified as regulator of JNK pathway. JNK1 and JNK2 have broad tissue distribution and play a potential role in insulin resistance, inflammation and cell signaling. JNK3 is predominantly found in the CNS neurons, making it an attractive target for neurodegenerative disorders. In this review, we summarize the evidence supporting JNK as a potent therapeutic target, and small molecules from various chemical classes as JNK inhibitors.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2015 |
|---|---|
| Erschienen: |
2015 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:7 |
|---|---|
| Enthalten in: |
Future medicinal chemistry - 7(2015), 15 vom: 25., Seite 2065-86 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Kumar, Ankit [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
EC 2.7.11.24 |
|---|
| Anmerkungen: |
Date Completed 17.08.2016 Date Revised 11.03.2022 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.4155/fmc.15.132 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM254059643 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM254059643 | ||
| 003 | DE-627 | ||
| 005 | 20231224171544.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231224s2015 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.4155/fmc.15.132 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n0846.xml |
| 035 | |a (DE-627)NLM254059643 | ||
| 035 | |a (NLM)26505831 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Kumar, Ankit |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a JNK pathway signaling |b a novel and smarter therapeutic targets for various biological diseases |
| 264 | 1 | |c 2015 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 17.08.2016 | ||
| 500 | |a Date Revised 11.03.2022 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a JNK pathway regulates various physiological processes including inflammatory responses, cell differentiation, cell proliferation, cell death, cell survival and expression of proteins. Deregulation of JNK is linked with various diseases including neurodegenerative disease, autoimmune disease, diabetes, cancer, cardiac hypertrophy and asthma. Three distinct genes JNK1, JNK2 and JNK3 have been identified as regulator of JNK pathway. JNK1 and JNK2 have broad tissue distribution and play a potential role in insulin resistance, inflammation and cell signaling. JNK3 is predominantly found in the CNS neurons, making it an attractive target for neurodegenerative disorders. In this review, we summarize the evidence supporting JNK as a potent therapeutic target, and small molecules from various chemical classes as JNK inhibitors | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Review | |
| 650 | 7 | |a Protein Kinase Inhibitors |2 NLM | |
| 650 | 7 | |a Small Molecule Libraries |2 NLM | |
| 650 | 7 | |a JNK Mitogen-Activated Protein Kinases |2 NLM | |
| 650 | 7 | |a EC 2.7.11.24 |2 NLM | |
| 700 | 1 | |a Singh, Umesh K |e verfasserin |4 aut | |
| 700 | 1 | |a Kini, Suvarna G |e verfasserin |4 aut | |
| 700 | 1 | |a Garg, Vikas |e verfasserin |4 aut | |
| 700 | 1 | |a Agrawal, Saurabh |e verfasserin |4 aut | |
| 700 | 1 | |a Tomar, Praveen K |e verfasserin |4 aut | |
| 700 | 1 | |a Pathak, Prateek |e verfasserin |4 aut | |
| 700 | 1 | |a Chaudhary, Anurag |e verfasserin |4 aut | |
| 700 | 1 | |a Gupta, Pratibha |e verfasserin |4 aut | |
| 700 | 1 | |a Malik, Amrita |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Future medicinal chemistry |d 2009 |g 7(2015), 15 vom: 25., Seite 2065-86 |w (DE-627)NLM194822109 |x 1756-8927 |7 nnns |
| 773 | 1 | 8 | |g volume:7 |g year:2015 |g number:15 |g day:25 |g pages:2065-86 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.4155/fmc.15.132 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 7 |j 2015 |e 15 |b 25 |h 2065-86 | ||